DK497983D0 - Fremgangsmade til fremstilling af 5-phenyl-hydantoin-derivater eller farmaceutisk acceptable salte deraf - Google Patents

Fremgangsmade til fremstilling af 5-phenyl-hydantoin-derivater eller farmaceutisk acceptable salte deraf

Info

Publication number
DK497983D0
DK497983D0 DK4979/83A DK497983A DK497983D0 DK 497983 D0 DK497983 D0 DK 497983D0 DK 4979/83 A DK4979/83 A DK 4979/83A DK 497983 A DK497983 A DK 497983A DK 497983 D0 DK497983 D0 DK 497983D0
Authority
DK
Denmark
Prior art keywords
phenyl
procedure
preparation
acceptable salts
pharmaceutical acceptable
Prior art date
Application number
DK4979/83A
Other languages
English (en)
Inventor
James P Rizzi
Rodney C Schnur
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/438,200 external-priority patent/US4457939A/en
Priority claimed from US06/438,199 external-priority patent/US4452806A/en
Application filed by Pfizer filed Critical Pfizer
Publication of DK497983D0 publication Critical patent/DK497983D0/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/008Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with tri- or tetrahalomethyl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK4979/83A 1982-11-01 1983-10-31 Fremgangsmade til fremstilling af 5-phenyl-hydantoin-derivater eller farmaceutisk acceptable salte deraf DK497983D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/438,200 US4457939A (en) 1982-11-01 1982-11-01 Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl)hydantoins
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins

Publications (1)

Publication Number Publication Date
DK497983D0 true DK497983D0 (da) 1983-10-31

Family

ID=27031578

Family Applications (1)

Application Number Title Priority Date Filing Date
DK4979/83A DK497983D0 (da) 1982-11-01 1983-10-31 Fremgangsmade til fremstilling af 5-phenyl-hydantoin-derivater eller farmaceutisk acceptable salte deraf

Country Status (6)

Country Link
EP (1) EP0112620B1 (da)
AU (1) AU540542B2 (da)
DE (1) DE3368614D1 (da)
DK (1) DK497983D0 (da)
IE (1) IE56417B1 (da)
IL (1) IL70097A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2102353A2 (en) * 2006-12-04 2009-09-23 DSM IP Assets B.V. Whole-cell catalytic system comprising a hydantoinase, a racemase and a carbamoylase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5492961A (en) * 1977-12-29 1979-07-23 Ajinomoto Co Inc Production of 5-arylhydantoin
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
IL70097A0 (en) 1984-01-31
EP0112620A1 (en) 1984-07-04
EP0112620B1 (en) 1986-12-30
IE832538L (en) 1984-05-01
AU2081983A (en) 1984-05-10
DE3368614D1 (en) 1987-02-05
IE56417B1 (en) 1991-07-31
AU540542B2 (en) 1984-11-22
IL70097A (en) 1987-11-30

Similar Documents

Publication Publication Date Title
DK146482A (da) Fremgangsmaade til fremstilling af cyklobutylaminderivater eller farmaceutisk acceptable salte deraf
DK163359C (da) Analogifremgangsmaade til fremstilling af n-imidazolylderivater af bicycliske forbindelser eller pharmaceutisk acceptable salte deraf
DK161968C (da) Analogifremgangsmaade til fremstilling af imidazo-pyrazolo-pyrimidiner eller farmaceutisk acceptable salte deraf
DK552581A (da) Fremgangsmaade til fremstilling af 3-pyridylaklyl-indol-forbindelser eller farmaceutisk acceptable salte deraf
DK503080A (da) Fremgangsmaade til fremstilling af imdazolderivater eller salte deraf
DK70083D0 (da) Fremgangsmade til fremstilling af pyrroleddikesyreamider eller salte deraf
DK160561C (da) Analogifremgangsmaade til fremstilling af 3-aminopregn-5-enderivater eller salte deraf
DK159427C (da) Analogifremgangsmaade til fremstilling af antiallergisk virksomme quinolinonderivater eller salte deraf
DK413883A (da) Fremgangsmaade til fremstilling af c-20-modificerede macrolidderivater eller farmaceutisk acceptable salte deraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK161699C (da) Analogifremgangsmaade til fremstilling af 4-aryl-4-piperidincarbinoler eller farmaceutisk acceptable salte deraf
DK232777A (da) Fremgangsmade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK448783A (da) Fremgangsmaade til fremstilling af n-substituerede 2-(1-imidazolyl)-indoler eller farmaceutisk acceptable salte deraf
DK232677A (da) Fremgangsmade til fremstilling af dihydro eller tetrahydroiminothiaziner eller farmaceutisk acceptable salte deraf
DK85183D0 (da) Fremgangsmade til fremstilling af benzokondenserede tricycliske forbindelser eller farmaceutisk acceptable salte deraf og mellemprodukter derved
DK165983C (da) Fremgangsmaade til fremstilling af phosphorholdige antibiotiske forbindelser betegnet cl 1565-a, cl 1565-b og cl 1565-t eller farmaceutisk acceptable salte deraf
DK232877A (da) Fremgangsmade til fremstilling af 2-imino-3-aminothiazolidiner eller farmaceutisk acceptable salte deraf
DK386783A (da) Fremgangsmaade til fremstilling af benzamidderivater eller et farmaceutisk acceptabelt salt deraf
DK149823C (da) Fremgangsmaade til fremstilling af kijanimicin eller farmaceutisk acceptable salte heraf
DK224381A (da) Fremgangsmaade til fremstilling af benzazolderivater eller salte deraf
DK210183A (da) Fremgangsmaade til fremstilling af piperidinoquinazolin-forbindelser eller farmaceutisk acceptable salte deraf
DK476082A (da) Fremgangsmaade til fremstilling af phenolderivater eller salte deraf
DK226883A (da) Fremgangsmaade til fremstilling af trialkylsiliciumholdige phenylcycloalkan-forbindelser eller farmaceutisk acceptable salte deraf
DK499983A (da) Fremgangsmaade til fremstilling af 5-phenyl-hydantoin-forbindelser eller farmaceutisk acceptable salte deraf
DK497983D0 (da) Fremgangsmade til fremstilling af 5-phenyl-hydantoin-derivater eller farmaceutisk acceptable salte deraf